Innovative Strategies of MoonLake Immunotherape...

By João L. Carapinha

August 30, 2025

MoonLake Immunotherapeutics HS, under the leadership of CEO Jorge Santos da Silva, is reimagining traditional biotech strategies with a concentrated approach to immunotherapeutic drug development. Utilizing innovative nanobody technology, the comp...
AMALFI Trial: How Patch-Based ECG Monitoring Could Transform Remote Atrial Fi...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
EFPIA Response to Tariffs: Concerns Over U.S.-EU Trade Agreement Impact on Ph...
TAVI Cost-Effectiveness in Brazil: Balancing Coverage Expansion and Economic ...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
FDA Guidance on Overall Survival Assessment in Oncology Trials
Guiding the Future of Digital Cardiac Rehabilitation: NICE’s Conditiona...
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms
Unlocking Self-Care South Africa: Strategies and Challenges in Healthcare Reform